Some Fraud Claims Resurrected In Testosterone MDL

By John Kennedy (March 8, 2016, 9:32 PM EST) -- An Illinois federal judge on Monday brought back half a lawsuit filed by consumers who say drugmakers didn't warn about health problems linked to certain generic testosterone replacement therapy drugs, saying that he'd erred in ruling that some allegations were preempted by federal law.

In reconsidering his November ruling that claims about the drugs were preempted because the companies didn't have the power to unilaterally strengthen their warnings, U.S. District Judge Matthew Kennelly said that seven of the suit's 14 claims survived as long as they're based on allegations of fraudulent off-label marketing. The other seven claims, which dealt mainly with...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!